TXG R&D Expenses

10X Genomics Inc Class A · R&D Expenses

TXG logo

TXG R&D Expenses

Latest reported$56.79M
TXG Quarterly R&D Expenses ($14.79M → $56.79M)
High-resolution chart · PNG

TXG r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

10X Genomics Inc Class A R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
56,791,000
56,847,000
55,969,000
57,194,000
61,224,000
64,245,000
66,968,000
66,174,000
62,918,000
68,638,000
65,267,000
107,909,000
71,460,000
67,098,000
63,614,000
67,290,000
70,685,000
64,078,000
61,885,000
54,582,000
53,402,000
41,883,000
39,705,000
30,143,000
27,535,000
25,992,000
27,889,000
22,209,000
18,034,000
14,965,000
13,080,000
11,085,000
11,444,000
14,789,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.